NCT00203528View on ClinicalTrials.gov

Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

February 28, 2007

Conditions
Substance AbuseBipolar Depression
Interventions
DRUG

divalproex sodium ER

DRUG

risperidone

Trial Locations (1)

35404

Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Tuscaloosa Research & Education Advancement Corporation

OTHER

NCT00203528 - Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder | Biotech Hunter | Biotech Hunter